Daniel Meibom

8PUBLICATIONS
10CO-AUTHORS
Fluid-structure interaction and aeroacousticsProteins and peptidesCheminformatics and quantitative structure-activity relationshipsBiologically active moleculesCognition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 16, 2025
Linker-Determined Folding and Hydrophobic Interactions Explain a Major Difference in PROTAC Cell Permeability.

Vasanthanathan Poongavanam, Stefan Peintner, Yordanos Abeje

|Dec 18, 2024
Impact of Linker Composition on VHL PROTAC Cell Permeability.

Yordanos Esubalew Abeje, Lianne H E Wieske, Vasanthanathan Poongavanam

|Feb 13, 2024
BAY-9835: Discovery of the First Orally Bioavailable ADAMTS7 Inhibitor.

Daniel Meibom, Pierre Wasnaire, Kristin Beyer

|Sep 05, 2023
Design and Preclinical Characterization Program toward Asundexian (BAY 2433334), an Oral Factor XIa Inhibitor for the Prevention and Treatment of Thromboembolic Disorders.

Susanne Roehrig, Jens Ackerstaff, Eloísa Jiménez Núñez

|Mar 18, 2023
BAY-6096: A Potent, Selective, and Highly Water-Soluble Adrenergic α<sub>2B</sub> Antagonist.

Daniel Meibom, Jutta Meyer, Clemens-Jeremias von Buehler

|Feb 23, 2023
Predictive Modeling of PROTAC Cell Permeability with Machine Learning.

Vasanthanathan Poongavanam, Florian Kölling, Anja Giese

Pageof 2

Frequent Collaborators

4 joint publications

Vasanthanathan Poongavanam

4 joint publications

Jan Kihlberg

3 joint publications

Mate Erdelyi

2 joint publications

Markus Follmann